Created by Italian art studio Quiet Ensemble, Solar Dust comes to Houston via Austria. Photo via posthtx.com

Experiencing art is no longer about just looking at paintings on a wall or sculptures on a stand. It's also about being immersed in the works, seeing them from all sides.

That's exactly what Solar Dust offers. The new immersive work will make its U.S. debut at POST Houston's Art Club, a black box art exhibition space and nightlife experience inside the downtown mixed-use development, food hall, and gathering spot.

Created by Italian art studio Quiet Ensemble, Solar Dust comes to Houston via Austria. Opening June 1, the pop-up exhibition features the immersive artwork exploring light, sound, and the interconnectedness of nature and technology.

In Solar Dust, state-of-the-art lasers fire at a mass of steel-filament tulle, animating an ever-shifting series of shadows that creates the illusion of suspended particles in space. Exhibit visitors are invited to contemplate the delicate balance between light and dark, sound and silence, order and chaos.

"We are thrilled about Solar Dust's US debut at POST in Houston, a global city renowned for its rich and diverse arts scene, which provides the perfect backdrop for our unconventional work,” said Nicolas Roziecki of Quiet Ensemble in a statement. “Solar Dust is not an immersive artwork; it's a captivating light installation that transforms an exhibition space into a celestial realm. We invite visitors and Houstonians alike to embark on this journey and immerse themselves in the allure of a three-dimensional glowing structure, evocative of celestial light dust."

In addition to showcasing the unique work, the pop-up exhibit also serves to introduce Houston to POST's Art Club concept, which officially debuts this fall in the venue's X Atrium. Expect a mash-up of programming and exhibits that borrow from nightclubs and art galleries. Sprawling across 40,000 square feet, the Art Club takes a fresh approach to limited-engagement installations by bringing a rotating roster of light and digital media artists and designers from around the world. The first season will be announced early this fall.

In the meantime, those wishing to see Solar Dust may do so for $7 via Eventbrite.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.